Pacific GeneTech Progresses Its US Headquarters Facility

Pacific GeneTech reports that it is progressing the development of its new US headquarters facility in Northwest Arkansas...

Pacific GeneTech Reports Positive Results for its Cross-protective Vaccine Targeting both Salmonella and E. coli in Swine

Pacific GeneTech reports positive results in a recent trial for its oral Salmonella-based cross-protective vaccine targeting Salmonella in swine...

Pacific GeneTech Demonstrates Safety of Proprietary Adjuvant in Dip/Immersion Vaccination of Rainbow Trout 

 Pacific GeneTech reports successful results in a recent safety trial for its patented adjuvant delivery system, Hercules, when used as a vaccine component in a dip/immersion vaccination in rainbow trout... 

Pacific GeneTech secures $10 Million financing to advance Novel Vaccine Platform and US Operations

Pacific GeneTech announced today it has secured $10 million of equity financing.  New investors in this round include FHB Ventures, the Arkansas Development Finance Authority (ADFA) and Simmons Foods...

Pacific GeneTech plans Arkansas production facility for animal vaccine licensed from Arkansas Agricultural Experiment Station

Arkansas Agricultural Experiment Station research on animal vaccines for economically important pathogens such as Salmonella, Eimeria and Avian influenza has led to a new manufacturing and business development by Pacific GeneTech.

Pacific GeneTech Announces New U.S. Corporate Headquarters in Northwest Arkansas

Pacific GeneTech (PGT) today announced plans to locate its U.S. headquarters to Northwest Arkansas (NWA).

Pacific GeneTech Appoints Industry Veteran Dr. Edward Fryar as a Member of the Board

Pacific GeneTech (PGT) today announces the appointment of Dr. Edward Fryar, Jr. to PGT’s Board of Directors.

Pacific GeneTech reports positive results for vaccine targeting E. coli in swine

Pacific GeneTech (PGT) reports positive results in a recent trial for its oral Salmonella-based cross-protective vaccine targeting E. coli in swine.  The study was conducted at TRB in the US.

Pacific GeneTech Establishes Canadian Subsidiary and joins Emergence Bioincubator

Pacific GeneTech (PGT) has established a subsidiary, Pacific GeneTech Canada Ltd, in Prince Edward Island, Canada. A main focus of PGT Canada would be research in aquaculture applications for PGT’s technologies.....

Pacific GeneTech announces the Appointment of Dr. Quentin Sattentau of The University of Oxford as a Scientific Advisor

Pacific GeneTech (PGT) announces Dr. Quentin Sattentau has joined its Scientific Advisory Board.  Dr. Sattentau has been working with PGT on the Hercules adjuvant delivery system program for over three years.....

Kemin licenses another poultry vaccine from Pacific GeneTech

Kemin Industries and Pacific GeneTech (PGT) have increased their commercial partnership to include the latter's Eimeria vaccine for poultry....

Kemin Industries Partners with Pacific GeneTech to Launch First Inactivated Eimeria Vaccine to Global Poultry Industry

Kemin Industries, a global ingredient manufacturer that strives to sustainably transform the quality of life every day for 80 percent of the world with its products and services, with its subsidiary Kemin Biologics, has signed an exclusive agreement with Pacific GeneTech (PGT) to license PGT’s TMH001 Eimeria vaccine for poultry .....

Pacific GeneTech turns focus to next candidates in vaccine pipeline

Pacific GeneTech (PGT) is looking to license out its second group of veterinary vaccines ....

Pacific GeneTech selected to present at 2020 Digital Animal Health Summit, formerly known as the KC Animal Health Investment Forum, on August 31 – September 2

Pacific GeneTech Adjuvant Technology Approved for Use With Medion Vaccine in Indonesia

Pacific GeneTech (PGT), a biologics company that develops and commercializes next-generation vaccines, received an Indonesian approval for its patented “Hercules” adjuvant for use with Medion’s coryza poultry vaccine ....

Indonesian poultry vaccine approval utilizes Pacific GeneTech adjuvant

Pacific GeneTech (PGT) has witnessed the first approval of the use of its adjuvant technology with a poultry vaccine.  Indonesian business Medion received domestic authorization for the use of PGT's Hercules adjuvant technology with its coryza poultry vaccine.....

Hong Kong start-up Pacific GeneTech joins global search for African swine fever vaccine 

The disease, for which no effective vaccine has made it to market, has resulted in hundreds of millions of pigs either dying or being culled globally.  Pacific GeneTech plans to conduct its ‘proof-of-concept’ clinical trial on 120 pigs in North America, at a cost of up to US$500,000 ....

Pacific GeneTech partners with EpiVax on a novel vaccine approach for ASF 

Hong Kong's Pacific GeneTech (PGT), a biologics company that develops and commercializes next-generation vaccines for areas of high unmet or undeserved needs in animal health and food safety, is collaborating with Rhode Island-based EpiVax, ....

Pacific GeneTech and EpiVax combine forces to work on ASF vaccine

Hong Kong's Pacific GeneTech (PGT) is to collaborate with US-based EpiVax to develop a vaccine for African swine fever (ASF).  PGT is a biologics company that develops and commercializes next-generation vaccines for unmet or underserved needs in animal health.....

Pacific GeneTech to commercialize poultry vaccine through Kemin pact

Hong Kong-based Pacific GeneTech (PGT) will take its veterinary vaccine business worldwide via an exclusive commercialization partnership with Kemin Industries.....

Salmonella vaccine will be commercialized in new partnership

Ingredients manufacturer Kemin Industries signed an exclusive agreement with Pacific GeneTech to commercialize a poultry salmonella vaccine that addresses multiple strains of the bacteria,.....

Kemin Industries Partners with Pacific GeneTech to Bring Salmonella Vaccine to Poultry Industry

Kemin Industries, a global ingredient manufacturer that strives to sustainably transform the quality of life every day for 80 percent of the world with its products and services, has signed an exclusive agreement with Pacific GeneTech (PGT), ....

Pacific GeneTech reports positive results for second inactivated Eimeria poultry vaccine trial at Southern Poultry Research

Pacific GeneTech (PGT) reports positive results in a recent trial for its inactivated recombinant Eimeria vaccine.  The study was conducted at the Southern Research Poultry in the US with Dr. Greg Mathis (a leading expert on Eimeria).....

Hercules shows promising vaccine adjuvant properties in a study conducted at Oxford

Pacific GeneTech (PGT) develops next-generation vaccine technologies, has just completed the second part of a mode of action study on their proprietary adjuvant “Hercules”, at the Sir William Dunn School of Pathology, University of Oxford.....

Pacific GeneTech selected as Emerging Company at Animal Health Innovation Asia, Hong Kong

The selection committee of the conference ANIMAL HEALTH INNOVATION ASIA, Hong Kong, selected Pacific GeneTech as one of 12 presenting emerging companies.  This conference is dedicated to showcasing to investors the most innovations in animal health and nutrition companies covering the companion, aquaculture and production animal space.

Pacific GeneTech sees positive findings for inactivated Eimeria poultry vaccine 

Hong Kong-based animal health firm Pacific GeneTech (PGT) has gained promising results in a recent trial for its inactivated recombinant Eimeria vaccine.....

Pacific GeneTech seeks extra out-licensing deals for adjuvant tech

Hong Kong-based veterinary vaccines specialist Pacific GeneTech (PGT) is hoping to secure further out-licensing deals for its clinically-proven Hercules adjuvant delivery system.....

Pacific GeneTech and Medion to set up Hercules adjuvant manufacturing in new facility

Pacific GeneTech (PGT) and Medion has signed a joint venture agreement and has completed the set-up of a manufacturing plant for the production of Hercules in Bandung, Indonesia.....

Pacific GeneTech selected as Emerging Company at Animal Health Investment Asia, Hong Kong

The selection committee of the conference ANIMAL HEALTH INVESTMENT ASIA, Hong Kong, selected Pacific GeneTech as one of 12 presenting emerging companies. This conference is dedicated to showcasing to investors the most innovative emerging animal health companies covering the companion, aquaculture and production animal space.

Cross-protection validated initial Toxoplasma gondii proof of concept trial

Pacific GeneTech (PGT), successfully completed a proof of concept trial against Toxoplasma gondii in mice.  .“This proof of concept study demonstrated that our recombinant vaccine including TRAP, MPP and HMGB1 .....

Pacific GeneTech to present at 13th Annual BIO Asia International Conference, Tokyo.

​

Hong Kong firm targets globalization of poultry vaccines

Hong Kong-based biotechnology company Pacific Gene Tech (PGT) said it is close to commercializing two poultry vaccines in the global animal health market.....